CAGGIA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 3.204
EU - Europa 2.132
AS - Asia 1.542
SA - Sud America 244
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 7.169
Nazione #
US - Stati Uniti d'America 3.146
DE - Germania 528
SG - Singapore 520
CN - Cina 498
GB - Regno Unito 487
IT - Italia 351
BR - Brasile 197
HK - Hong Kong 187
SE - Svezia 162
IE - Irlanda 136
RU - Federazione Russa 127
FI - Finlandia 114
VN - Vietnam 107
UA - Ucraina 66
FR - Francia 40
ID - Indonesia 37
TR - Turchia 37
KR - Corea 33
IN - India 31
CA - Canada 26
NL - Olanda 26
MX - Messico 23
BG - Bulgaria 21
AR - Argentina 19
PL - Polonia 16
JP - Giappone 15
BD - Bangladesh 11
ES - Italia 10
LT - Lituania 10
ZA - Sudafrica 10
AT - Austria 8
CO - Colombia 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
MA - Marocco 7
CL - Cile 6
CZ - Repubblica Ceca 6
TW - Taiwan 6
CH - Svizzera 5
EC - Ecuador 5
IQ - Iraq 5
IR - Iran 5
KE - Kenya 5
SA - Arabia Saudita 5
VE - Venezuela 5
LB - Libano 4
MY - Malesia 4
PK - Pakistan 4
BE - Belgio 3
IL - Israele 3
MK - Macedonia 3
PH - Filippine 3
SI - Slovenia 3
AU - Australia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 7.169
Città #
Ashburn 391
Singapore 332
Santa Clara 312
Southend 297
Chandler 215
Hong Kong 183
Hefei 178
Fairfield 174
Woodbridge 164
Dublin 136
Munich 130
Houston 109
Jacksonville 107
Nyköping 107
Dearborn 101
Dallas 100
Los Angeles 90
Wilmington 86
Chicago 84
Helsinki 80
Beijing 76
Seattle 74
London 69
New York 66
Cambridge 63
Modena 45
Ho Chi Minh City 40
Salt Lake City 37
Seoul 33
Enfield 32
Fremont 32
Ann Arbor 31
Bologna 27
Shanghai 26
Jakarta 25
The Dalles 24
Hanoi 23
Princeton 23
Milan 21
San Diego 21
Sofia 21
Eugene 19
Moscow 18
Phoenix 17
Rome 17
Tampa 17
São Paulo 16
Bremen 15
Council Bluffs 15
Turku 15
Reggio Emilia 14
Elk Grove Village 13
Falls Church 13
Izmir 13
Atlanta 12
Buffalo 11
Columbus 11
Des Moines 11
Frankfurt am Main 11
Guangzhou 11
Lancaster 10
Nanjing 10
Redondo Beach 10
Stockholm 10
Tokyo 10
Denver 9
Dong Ket 9
Kent 9
Lauterbourg 9
Orem 9
Poplar 9
Redwood City 9
San Jose 9
Warsaw 9
Istanbul 8
Mexico City 8
Brooklyn 7
Johannesburg 7
Nuremberg 7
Querétaro 7
San Francisco 7
Boardman 6
Cardiff 6
Chennai 6
Haarlem 6
Kunming 6
Miami 6
Newark 6
Norwalk 6
Ottawa 6
Parma 6
Portsmouth 6
Sterling 6
Brasília 5
Brno 5
Chengdu 5
Montreal 5
Nairobi 5
Napoli 5
Porto Alegre 5
Totale 4.743
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 542
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 385
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 353
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 342
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 318
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 308
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 302
Quality of life and anxious-depressive symptoms in cancer patients undergoing mindfulness-based interventions: Feasibility and preliminary outcomes on prospective single-centre case-control study (MIND4ME St.) 286
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 284
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 271
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 271
Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer. 262
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 257
Gene expression profile of the hippocampus of a behavioural model of depression 255
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 254
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 247
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 231
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 227
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 220
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 215
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 215
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges 207
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 172
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 169
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 153
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 125
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 121
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA) 111
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 106
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 8
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 5
Totale 7.222
Categoria #
all - tutte 26.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 0 32 69 33 36 43 34
2021/2022387 18 47 14 25 18 29 15 10 38 43 75 55
2022/2023759 66 92 46 71 48 69 12 57 170 9 85 34
2023/2024489 19 23 33 70 72 49 55 50 11 17 33 57
2024/20251.643 39 22 40 101 265 226 181 118 184 104 143 220
2025/20261.965 256 139 298 408 641 223 0 0 0 0 0 0
Totale 7.222